152 related articles for article (PubMed ID: 38457885)
1. Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis.
Liu C; Zhou W; Sun X; Zhang X; Xiao H; Yang H; Lin H; Lu Y; Liu Z; Qiu W; Kermode AG; Yang X; Wang Y
Mult Scler Relat Disord; 2024 May; 85():105478. PubMed ID: 38457885
[TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
[TBL] [Abstract][Full Text] [Related]
3. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
Front Immunol; 2021; 12():647618. PubMed ID: 33796113
[No Abstract] [Full Text] [Related]
4. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
Watanabe M; Nakamura Y; Michalak Z; Isobe N; Barro C; Leppert D; Matsushita T; Hayashi F; Yamasaki R; Kuhle J; Kira JI
Neurology; 2019 Sep; 93(13):e1299-e1311. PubMed ID: 31471502
[TBL] [Abstract][Full Text] [Related]
5. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
[TBL] [Abstract][Full Text] [Related]
6. Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Lin TY; Schindler P; Grittner U; Oertel FC; Lu A; Motamedi S; Yadav SK; Duchow AS; Jarius S; Kuhle J; Benkert P; Brandt AU; Bellmann-Strobl J; Schmitz-Hübsch T; Paul F; Ruprecht K; Zimmermann HG
Mult Scler Relat Disord; 2022 Nov; 67():104100. PubMed ID: 36049341
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4-IgG-seropositive neuromyelitis optica spectrum disorder.
Liu C; Xiao H; Zhang X; Zhao Y; Li R; Zhong X; Wang Y; Shu Y; Chang Y; Wang J; Li C; Lin H; Qiu W
Brain Behav; 2021 May; 11(5):e02125. PubMed ID: 33784027
[TBL] [Abstract][Full Text] [Related]
8. Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study.
Ashtari F; Ataei A; Kafieh R; Khodabandeh Z; Barzegar M; Raei M; Dehghani A; Mansurian M
Mult Scler Relat Disord; 2021 Jan; 47():102625. PubMed ID: 33227631
[TBL] [Abstract][Full Text] [Related]
9. Retinal structural and microvascular deterioration independent of optic neuritis in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders: An optical coherence tomography angiography study.
Wang M; Wang W; Liu S; Ma J; Wang X; Chou Y; Gan L; Zhang X; Shao E; Zhong Y; Xu Y
Mult Scler Relat Disord; 2024 Apr; 84():105423. PubMed ID: 38359691
[TBL] [Abstract][Full Text] [Related]
10. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
[TBL] [Abstract][Full Text] [Related]
11. A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Outteryck O; Majed B; Defoort-Dhellemmes S; Vermersch P; Zéphir H
Mult Scler; 2015 Dec; 21(14):1781-93. PubMed ID: 25828758
[TBL] [Abstract][Full Text] [Related]
12. Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode.
Peng C; Wang W; Xu Q; Yang M; Zhou H; Zhao S; Wei S
Acta Ophthalmol; 2017 Sep; 95(6):583-590. PubMed ID: 27775238
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum Disorder: Longitudinal Analysis of Serum Glial Fibrillary Acidic Protein.
Hyun JW; Kim Y; Kim SY; Lee MY; Kim SH; Kim HJ
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33846219
[TBL] [Abstract][Full Text] [Related]
14. Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study.
Ayoubi NKE; Moussa H; Younes A; Haddad R; Khoury SJ
Mult Scler Relat Disord; 2022 Dec; 68():104160. PubMed ID: 36113276
[TBL] [Abstract][Full Text] [Related]
15. High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status.
Bertsch-Gout M; Loeb R; Finch AK; Javed A; Bernard J
J Neurol Sci; 2018 Jan; 384():61-66. PubMed ID: 29249380
[TBL] [Abstract][Full Text] [Related]
16. High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders.
Liu C; Zhao L; Fan P; Ko H; Au C; Ng A; Au L; Wong A; Kermode AG; Mok V; Yan Y; Qiu W; Lau AY
J Clin Neurosci; 2021 Jan; 83():108-111. PubMed ID: 33317883
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography angiography (OCTA) in differential diagnosis of aquaporin-4 antibody seronegative NMOSD and multiple sclerosis.
Tiftikcioglu BI; Emre S; Idiman F; Idiman E
Mult Scler Relat Disord; 2022 Feb; 58():103503. PubMed ID: 35030370
[TBL] [Abstract][Full Text] [Related]
18. Retinal Optical Coherence Tomography in Neuromyelitis Optica.
Oertel FC; Specovius S; Zimmermann HG; Chien C; Motamedi S; Bereuter C; Cook L; Lana Peixoto MA; Fontanelle MA; Kim HJ; Hyun JW; Palace J; Roca-Fernandez A; Leite MI; Sharma S; Ashtari F; Kafieh R; Dehghani A; Pourazizi M; Pandit L; D'Cunha A; Aktas O; Ringelstein M; Albrecht P; May E; Tongco C; Leocani L; Pisa M; Radaelli M; Martinez-Lapiscina EH; Stiebel-Kalish H; Siritho S; de Seze J; Senger T; Havla J; Marignier R; Cobo-Calvo A; Bichuetti D; Tavares IM; Asgari N; Soelberg K; Altintas A; Yildirim R; Tanriverdi U; Jacob A; Huda S; Rimler Z; Reid A; Mao-Draayer Y; Soto de Castillo I; Petzold A; Green AJ; Yeaman MR; Smith T; Brandt AU; Paul F
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34526385
[TBL] [Abstract][Full Text] [Related]
19. Blood sphingolipid as a novel biomarker in patients with neuromyelitis optica spectrum disorder.
Kim H; Kim HJ; So J; Kim JY; Jung HJ; Kim S; Seo D; Kim HJ; Song HE; Lim YM; Yoo HJ; Lee EJ
Mult Scler Relat Disord; 2024 May; 85():105551. PubMed ID: 38564996
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder.
Li Y; Liu Y; Zhao W; An X; Zhang F; Zhang TX; Liu Y; Du C; Zeng P; Yuan M; Zhang N; Zhang C
J Neuroimmunol; 2023 Nov; 384():578218. PubMed ID: 37801952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
